Oxidized low-density lipoprotein, angiotensin II and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis

International Journal of Cardiology

Volumn 145, Issue 3, 2010, Pages 444-449

  Côté, Nancy ^a   Pibarot, Philippe ^b   Pépin, Andrée ^a   Fournier, Dominique ^a   Audet, Audrey ^a   Arsenault, Benoît ^b   Couture, Christian ^b   Poirier, Paul ^b   Després, Jean Pierre ^b   Mathieu, Patrick ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Angiotensin II; Aortic stenosis; Oxidized LDL; Prehypertension

Indexed keywords

ADIPONECTIN; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; INTERLEUKIN 6; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL ARTICLE; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; MALE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PREHYPERTENSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADIPONECTIN; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; HUMANS; INTERLEUKIN-6; LINEAR MODELS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDITIS; OXIDATIVE STRESS; PREHYPERTENSION; RENIN-ANGIOTENSIN SYSTEM; TUMOR NECROSIS FACTOR-ALPHA; WAIST CIRCUMFERENCE;

EID: 78650010990     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.05.054     Document Type: Article

References (32)

1. C. Cote, P. Pibarot, and J.P. Despres Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis Heart 94 2008 1175 1180
2. T. Gotoh, T. Kuroda, and M. Yamasawa Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study) Am J Cardiol 76 1995 928 932
3. W.S. Aronow, K.S. Schwartz, and M. Koenigsberg Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients Am J Cardiol 59 1987 998 999 (Pubitemid 17074253)
4. E.R. Mohler, M.J. Sheridan, R. Nichols, W.P. Harvey, and B.F. Waller Development and progression of aortic valve stenosis: atherosclerosis risk factors-a causal relationship? A clinical morphologic study Clin Cardiol 14 1991 995 999
5. P.M. Hoagland, E.F. Cook, M. Flatley, C. Walker, and L. Goldman Case-control analysis of risk factors for presence of aortic stenosis in adults (age 50 years or older) Am J Cardiol 55 1985 744 747
6. S. Deutscher, H.E. Rockette, and V. Krishnaswami Diabetes and hypercholesterolemia among patients with calcific aortic stenosis J Chronic Dis 37 1984 407 415
7. B.F. Stewart, D. Siscovick, and B.K. Lind Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study J Am Coll Cardiol 29 1997 630 634
8. A. Zezulka, J. Mackinnon, and D.G. Beevers Hypertension in aortic valve disease and its response to valve replacement Postgrad Med J 68 1992 180 185
9. A.V. Chobanian, G.L. Bakris, and H.R. Black The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
10. R.S. Vasan, M.G. Larson, and E.P. Leip Impact of high-normal blood pressure on the risk of cardiovascular disease N Engl J Med 345 2001 1291 1297
11. J. Hsia, K.L. Margolis, and C.B. Eaton Prehypertension and cardiovascular disease risk in the Women's Health Initiative Circulation 115 2007 855 860
12. A.V. Kshirsagar, M. Carpenter, H. Bang, R.E. Wyatt SB, and Colindres Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease Am J Med 119 2006 133 141
13. A.I. Qureshi, M.F. Suri, J.F. Kirmani, A.A. Divani, and Y. Mohammad Is prehypertension a risk factor for cardiovascular diseases? Stroke 36 2005 1859 1863
14. Y. Zhang, E.T. Lee, and R.B. Devereux Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study Hypertension 47 2006 410 414 (Pubitemid 43740283)
15. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
16. D. Mohty, P. Pibarot, and J.P. Despres Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis Arterioscler Thromb Vasc Biol 28 2008 187 193
17. K.D. O Brien, J.L. Probstfield, and M.T. Caulfield Angiotensin-converting enzyme inhibitors and change in aortic valve calcium Arch Intern Med 165 2005 858 862
18. R.O. Bonow, B.A. Carabello, and K. Chatterjee 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 52 2008 e1 e142
19. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
20. A.C. St-Pierre, B. Cantin, and G.R. Dagenais Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study Arterioscler Thromb Vasc Biol 25 2005 553 559 (Pubitemid 40315677)
21. J.C. Hogue, B. Lamarche, and D. Gaudet Association of heterozygous familial hypercholesterolemia with smaller HDL particle size Atherosclerosis 190 2007 429 435
22. P. An, T. Rice, and J. Gagnon Segregation analysis of apolipoproteins A-1 and B-100 measured before and after an exercise training program: the HERITAGE Family Study Arterioscler Thromb Vasc Biol 20 2000 807 814 (Pubitemid 30151697)
23. J. Bohlender, J. Menard, J. Wagner, F.C. Luft, and D. Ganten Human renin-dependent hypertension in rats transgenic for human angiotensinogen Hypertension 27 1996 535 540 (Pubitemid 26084621)
24. Z.V. Wang, and P.E. Scherer Adiponectin, cardiovascular function, and hypertension Hypertension 51 2008 8 14
25. R.M. Touyz Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44 2004 248 252
26. C. Chrysohoou, D.B. Panagiotakos, and C. Pitsavos The association between pre-hypertension status and oxidative stress markers related to atherosclerotic disease: the ATTICA study Atherosclerosis 192 2007 169 176
27. K.D. O Brien, D.M. Shavelle, and M.T. Caulfield Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma Circulation 106 2002 2224 2230
28. J.J. Kaden, R. Kilic, and A. Sarikoc Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification Int J Mol Med 16 2005 869 872
29. A.M. Sironi, A. Pingitore, and S. Ghione Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat Hypertension 51 2008 282 288
30. M. Briand, I. Lemieux, and J.G. Dumesnil Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis J Am Coll Cardiol 47 2006 2229 2236
31. C.M. Otto Calcific aortic stenosis-time to look more closely at the valve N Engl J Med 359 2008 1395 1398
32. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150